Skip to content
Lupus Association of NSW Inc.
Lupus Association of NSW Inc.
The Quest for a Cure
1800 802 088

Donate Now

  • Home
  • Understanding Lupus
    • What is Lupus?
    • Signs and Symptoms of Lupus
    • Diagnosing Lupus
    • FAQs about Lupus
  • How lupus affects the body
    • How does lupus affect the body
    • Lupus and the Kidneys
    • Infections
    • Photosensitivity
  • Living with Lupus
    • Lupus and COVID-19
    • Coronavirus, stress and mental health
    • Looking after your well-being
    • Tips for Living with Lupus
    • Diet and Exercise
    • Medications
    • Managing Pain
    • Managing Fatigue
  • Sjogren’s Syndrome
    • What is Sjögren’s Syndrome?
    • Signs and Symptoms of Sjögren’s
    • Diagnosing Sjögren’s Syndrome
    • Treating Sjögren’s Syndrome
    • Tips for Living with Sjögren’s Syndrome
  • News
    • News and Events
    • Lupus Stories
    • Research
      • Research and Reports
      • The Monash Lupus Clinic
  • About Us
    • Mission Statement
    • Our History
    • Contact
    • Privacy Policy
    • Support
    • Other Lupus Websites
    • Donate
  • Home
  • Understanding Lupus
    • What is Lupus?
    • Signs and Symptoms of Lupus
    • Diagnosing Lupus
    • FAQs about Lupus
  • How lupus affects the body
    • How does lupus affect the body
    • Lupus and the Kidneys
    • Infections
    • Photosensitivity
  • Living with Lupus
    • Lupus and COVID-19
    • Coronavirus, stress and mental health
    • Looking after your well-being
    • Tips for Living with Lupus
    • Diet and Exercise
    • Medications
    • Managing Pain
    • Managing Fatigue
  • Sjogren’s Syndrome
    • What is Sjögren’s Syndrome?
    • Signs and Symptoms of Sjögren’s
    • Diagnosing Sjögren’s Syndrome
    • Treating Sjögren’s Syndrome
    • Tips for Living with Sjögren’s Syndrome
  • News
    • News and Events
    • Lupus Stories
    • Research
      • Research and Reports
      • The Monash Lupus Clinic
  • About Us
    • Mission Statement
    • Our History
    • Contact
    • Privacy Policy
    • Support
    • Other Lupus Websites
    • Donate

Phase 3 Trial – Benlysta

Phase 3 Trial Finds Benlysta Significantly Improves Kidney Response in People with Lupus Nephritis

UPDATE 16/09/2020

In new results on the international phase 3 clinical trial (BLISS-LN) of the drug Benlysta (belimumab), researchers found that Benlysta reduced the risk of worsening kidney function during the study by almost 50%, compared with standard therapy alone.

The groundbreaking results from the phase 3 BLISS-LN clinical trial could lead to Benlysta becoming the first drug approved by the Food and Drug Administration (FDA) (United States of America) to treat lupus nephritis, the most common severe complication of SLE that could lead to end-stage kidney disease and death.

Read the Study

Author: admin

Post navigation

PreviousPrevious post:US FDA approve BenlystaNextNext post:RUNWEST 2020

Related posts

Lupus Clinical Trial Awareness in Australia – Now Closed
12/03/2023
Lupus Sub Group of Type 2
10/08/2022
mRNA COVID-19 Vaccine
01/08/2022
WLF Global Survey of People Living with Lupus
05/05/2022
New cutaneous lupus erythematosus clinical trial in Victoria
13/09/2021
FDA Approves Saphnelo™ as New Treatment for Lupus
06/08/2021

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

clear formPost comment

Items in this Section
Stay in touch
Address: 55 Wicks Rd
North Ryde NSW 2113
 
Phone: (02) 9878 6055
Email: info@lupusaust.org.au
A.B.N: 25 876 911 996
Useful Links
  • Other Lupus Websites
Latest Tweets
World Lupus Day is Wednesday May 10. Let's work together to raise awareness and beat this monster!
Donations
  • How To Donate
  • Privacy Policy
Donate Now!
© Lupus Association of NSW Inc.

Webmaster - admin@lupusnsw.org.au